Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
71 studies found for:    "Primary biliary cirrhosis"
Show Display Options
Rank Status Study
21 Withdrawn Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: fenofibrate;   Drug: placebo
22 Completed Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: NGM282
23 Active, not recruiting
Has Results
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: obeticholic acid (OCA)
24 Completed Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: NGM282;   Biological: Placebo
25 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: ursodeoxycholic acid
26 Completed Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: UDCA (Ursodeoxycholic acid)
27 Withdrawn An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: LUM001
28 Terminated Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: budesonide;   Drug: budesonide placebo
29 Terminated Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis (PBC)
Interventions: Drug: Placebo Comparator;   Drug: Experimental: MBX-8025 50 mg;   Drug: Experimental: MBX-8025 200 mg
30 Not yet recruiting MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: MBX-8025 5 mg Capsule;   Drug: MBX-8025 10 mg Capsule;   Drug: MBX-8025 25 mg Capsule
31 Recruiting A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cirrhosis
Interventions: Drug: LJN452;   Drug: Placebo
32 Active, not recruiting B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
Conditions: Fatigue;   Primary Biliary Cirrhosis
Interventions: Biological: Rituximab;   Other: Placebo
33 Recruiting Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cirrhosis
Intervention:
34 Completed Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis;   Hypercholesterolemia
Intervention: Drug: Atorvastatin
35 Completed Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
Conditions: Fatigue;   Primary Biliary Cirrhosis
Intervention: Drug: Modafinil
36 Withdrawn Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
Conditions: Primary Biliary Cirrhosis;   Autoimmune Hepatitis
Intervention: Drug: Budesonide
37 Completed
Has Results
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: PBC;   Primary Biliary Cirrhosis
Interventions: Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic Acid
38 Terminated Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
Condition: Primary Biliary Cirrhosis
Intervention: Drug: NI-0801
39 Recruiting Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
40 Recruiting Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.